§ Funding Round
Series E funding round for Carmot Therapeutics raising $150M in May 2023
Series E funding round for Carmot Therapeutics raising $150M in May 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | anthony philippakis | |
MPM Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Franklin Templeton | — | — |
Frazier Life Sciences | — | — |
Janus Henderson Investors | — | — |
Millennium Management | — | — |
| Organization | — | |
TCGX | — | — |
| Organization | — | |
Willett Advisors | — | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$374.5M
Top Valuation
-
Carmot Therapeutics raised $150M in a Series E round.
The round was announced on 05/01/23.
The round was led by deep track capital.
